Downregulation of HIF2α was shown to be sufficient to suppress tumorigenesis in VHL-defective ccRCC cells, while stable expression of VHL-resistant HIF2α can promote tumor growth in ccRCC cells reconstituted with VHL [26, 27]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.